Streetwise Reports' Article Archives — Current Month (14)
California Gold Mining Full Speed Ahead in Hemp (04/18/2019)
Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market.
This company is targeting geographies where the cannabis market is growing rapidly.
An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker.
Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock.
Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report.
This technology company continues to diversify the end markets for its e-commerce platform.
Canadian Tech Firm Secures Largest Contract to Date (04/06/2019)
The new client, in the U.S., is a state governmental agency.
The surgical imaging firm continues to advance its first medical device toward commercialization.
This represents the company's expansion into another business area.
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app.
Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report.
A ROTH Capital Partners report reviewed the numbers for 2018 and explained why this Colorado-based company should perform well this year.
This represents a major milestone for the firm on its path to commercializing its products.
Best-of-Breed Hemp/CBD Producers (04/02/2019)
Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed."
|"DRRX initiated a 28-day Phase 1b trial of DUR-928 in NASH patients."|
|"Multiple players are at the table with PMN for a licensing deal."|